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Abstract 
Background: The growing awareness of the transfusion associated morbidity and mortality 
necessitates investigations into the underlying mechanisms. Small animal have been the 
dominant transfusion models but have significant limitations. This study sought to develop 
and evaluate a comprehensive large animal (ovine) model of transfusion that would 
encompass: blood collection, processing, storage, compatibility testing and transfusion 
outcomes.   
Study design and methods: Twenty-four units of whole blood were collected from 12 
healthy Merino adult male sheep and processed into packed red blood cells (PRBC). Baseline 
haematological values of sheep blood and PRBC were analysed. Biochemical changes in 
ovine PRBC packs were monitored and characterized during 42 days of storage. 
Immunologic compatibility of the blood was confirmed with sera from potential recipient 
sheep using a saline agglutination crossmatch. Following confirmation of compatibility, 2 
units of PRBC were transfused into each recipient sheep (n=12). 
Results: Methods for collection, processing, crossmatching and transfusion of sheep blood 
were established. Ovine RBCs are smaller, higher in number, but have similar mean cell 
haemoglobin concentration than human RBCs. The ovine PRBC showed improved storage 
properties in SAGM when compared with previous studies of human PRBC. Although 
haemolysis was at the upper limit at day 42, ovine PRBC met the human PRBC 
specifications. In all, 77 compatibility tests were performed and 18.2% were incompatible. 
No adverse reaction occurred in recipient sheep during blood transfusion. 
Conclusion: These findings validate the application of the ovine model for future blood 
transfusion studies and demonstrate the need of compatibility testing in animal models. 
 
Key Words: ovine model, blood transfusion, storage lesion, compatibility test 
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Introduction 
 Blood transfusion is an essential part of modern medicine. While blood transfusion 
can be life-saving it is not without risk [1]. Specific pathologies associated with transfusion 
include transfusion-related acute lung injury (TRALI), transfusion related 
immunomodulation (TRIM), circulatory overload, bacterial infections and haemolytic 
transfusion reactions are complications that can lead to deleterious outcomes [2-4]. 
Additionally, there is a growing body of evidence indicating an association between 
transfusion, especially of aged/stored blood products, and increased levels of morbidity and 
mortality in patients [5, 6]. This has prompted the development of multicentre clinical trials 
that aim to answer this question from a clinical perspective. Such trials, however, will not 
shed any light on the underlying pathological mechanisms.  
Ethical issues limit the research that can be undertaken in humans, necessitating the 
development of clinically relevant animal models of transfusion to investigating the 
mechanism of adverse transfusion reactions and poor clinical outcomes. However, the value 
of any information generated from animal models, is defined by the scope as well of 
limitations of the animal model. Murine models have been used extensively because of their 
relatively low cost and the ease of accessibility.  However, the small size of mice and rats 
limits the volume of blood samples that can be collected and prevents the use of the standard 
blood collection packs. In addition, the lifespan of murine red blood cells (RBCs) is about 
half that of humans [7, 8]. We also noted the absence of pre-transfusion compatibility testing 
in many animal transfusion studies. These factors fuelled our quest to develop a 
comprehensive and clinically relevant in vivo transfusion model that would support 
transfusion research investigation by mimicking the human cycle of blood donation, 
processing, compatibility testing and monitoring of transfusion outcomes.   
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 This study elected to develop a clinically relevant model using sheep because their 
anatomy, hemodynamic and microcirculatory characteristics and RBCs lifespan are very 
similar to humans (~120 days) [9-12]. 
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Methods 
This study was approved by the University Animal Research Ethics Committee of the 
Queensland University of Technology and University of Queensland, and all experiments 
were conducted in accordance with the Australian Code of Practice for the Care and Use of 
Animals for Scientific Purposes.  
 
Ovine blood collection protocol 
Two units of whole blood were collected from each of twelve male Merino sheep aged 
between 1-3 years and weighing of 40.71.7kg (meanSD) as part of another haemorrhage 
study (Vox ref). In brief, the sheep were instrumented under ketamine/midazolam anesthesia 
and monitored for arterial blood pressure, continuous cardiac output, mixed venous oxygen 
saturation and temperature. Sheep were ventilated throughout the experiment with a 
Hamilton Galileo ventilator at 12–15 breaths per minute. 
Following a period of stabilisation two units of whole blood (40020mL per unit) were 
collected from each sheep via a 8.5G venous sheath placed in the left internal jugular vein at 
flow rate 80-100mL/min for 5-8mins/bag into separate Leukotrap WB blood packs (Pall 
Medical, UK), containing 63mL of citrate, phosphate and dextrose (CPD) as an anticoagulant 
solution each. Additionally, a tube of Ethylenediaminetetraacetic acid (EDTA) blood 
(Greiner Bio-one Vacuette

, Thailand) was collected from the diversion pouch of the blood 
pack for full blood counts. 
 
Processing and storage of donor blood 
After 2 hours incubation at room temperature the whole blood was passed through the 
attached leukofilter. As ovine RBC are significantly smaller the whole blood was centrifuged 
at 5000g for 45 minutes and separated into plasma and packed red blood cell (PRBC) using a 
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manual Fenwal plasma extractor (Baxter, USA). The ovine PRBC (ovPRBC) were 
suspended in saline-adenine-glucose-mannitol (SAGM) additive solution, and stored under 
standard storage conditions at 2-6
0
C prior to transfusion. 
 
Quality assessment 
The EDTA blood samples (n=12) and a segment from the corresponding prepared ovPRBC 
units (n=24) were evaluated for pH, potassium, glucose and lactate using a Radiometer 
ABL825 blood gas analyser (Radiometer, Copenhagen, Denmark). The RBC volume, 
haemoglobin and haematocrit, mean corpuscular volume (MCV), mean corpuscular 
haemoglobin (MCH) and mean corpuscular haemoglobin concentration (MCHC) were also 
measured using the Beckman and CoulterAct diffhaematology analyser (Beckman 
Coulter Inc, Ireland). Subsequently, samples were aseptically collected from ovPRBC units 
were analysed on days 1, 5, 7, 14, 21, 28, 35 and 42 to determine the effects of storage. The 
degree of haemolysis in stored samples was determined by measuring supernatant 
haemoglobin concentration after centrifugation of ovPRBC using a portable HemoCue

 Hb 
201
+
 Photometer System (HemoCue AB, Ängelholm, Sweden) [13]. The percentage 
haemolysis was calculated as follows: (100-Hct) x free plasma Hb (g/L)/ total Hb (g/L). 
 
Compatibility testing 
Compatibility testing between donor ovPRBC and recipient sheep RBC was performed to 
avoid haemolytic transfusion reactions. Compatibility was confirmed by four procedures 
involving two drops of recipient sheep sera mixed with 1 drop of 5% donor sheep RBC in 
phosphate buffered saline (PBS) each. 
(i) Immediate centrifugation at 390g for 15sec and examined macroscopically for 
agglutination. The strength of agglutination was scored on a scale of 0-4 [14]. 
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(ii) Incubated at room temperature for 30min, then centrifuged as above and 
examined macroscopically for agglutination. 
(iii) Incubated at 370C for 30 minutes, and then centrifuged and examined. 
(iv) Tube (iii) was then centrifuged at 540g for 1min; the supernatant was removed 
and replaced by a drop of 10% albumin and incubated at 37
0
C for another 30 
minutes before examination macroscopically for agglutination. 
The ovPRBC was considered compatible when all 4 tests were negative [Fig 1]. 
 
Ovine Blood Transfusion 
Two units of compatible ovPRBC were transfused into sheep that had been bled of 30% of 
their blood volume. This was followed by 4% albumin to achieve volume replacement. Six 
sheep received fresh (< 5-day old) ovPRBC and another six received stored (35-42 days old) 
ovPRBC. Transfused sheep were continuously monitored for 4 hours post-transfusion.    
 
Statistics 
All data are presented as meanstandard deviation (SD) of the mean and ranges. Significance 
between groups was determined based on planned comparisons using a 1-way ANOVA. 
Posterior Bonferroni’s test was performed to determine difference between groups and 
baseline (GraphPad Prism6). P values of less than 0.05 were considered to be statistically 
significant.
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Results 
Ovine haematology 
Baseline EDTA blood samples from 12 healthy male Merino sheep were analysed and 
compared with healthy human male values (Table1). The red blood cell counts (RBCC) in 
ovine blood was higher (9.85-13.52 x10
12
/L) compared with that of humans (4.60-6.00 
x10
12
/L). The range of measured haemoglobin (Hb) and haematocrit (Hct) levels in sheep 
blood overlapped that of humans (115-156g/L vs. 140-180g/L and 35.0-48.4% vs. 40-54% 
respectively). Mean cell volume (MCV) and mean cell haemoglobin (MCH) values were 
considerably lower from human  (31.6-37.9fL vs. 80-100fL; 10.8-14.1pg vs. 26-32pg 
respectively). The range of ovine mean cell haemoglobin concentration (MCHC) was similar 
to that of humans (314-342g/L vs. 320-360g/L).  
 
Quality assessment of ovPRBC units 
Twenty-four ovPRBC units were analysed and compared with human PRBC units (Table1).  
According to current standard requirements by Council of Europe Guideline the Hb level 
should be higher than 45g and the Hct level between 50-70% in human PRBC units [15]. The 
Hb level of ovPRBC (136-184g/L) surpassed that requirement but the Hct (39.0-71.3%) was 
slightly below to the required level. In spite of these differences ovPRBC haematology 
parameters were proportional to the human equivalent.  
 
Storage-related changes in ovPRBC units 
In this study, we also examined the following storage lesion parameters: haemolysis, 
potassium, glucose, lactate and pH in 10 units of ovPRBC over 42 days. Significant 
haemolysis was evident in ovPRBC from day 35 (P < 0.0001 vs. day 1) and was further 
increased at day 42 [Fig 2A]. From day 5 the potassium level of sheep PRBC steadily 
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increased to peak at 6.77mmol/L on day 28 after which it was relatively stable [Fig 2B]. 
There was a statistically significant decline in glucose levels evident after day 14 of storage 
(P = 0.009 vs. day 1) [Fig 2C]. This corresponded with a significant increase in lactate levels 
that was evident from day 28 (P = 0.0028 vs. day 1) [Fig 2D]. The pH on day 1 was 
7.0140.047 and remained unchanged throughout the 42-day storage period (P = 0.999 vs. 
day 1) [data not shown]. 
 
Blood compatibility testing 
In the total group, 77 compatibility tests were performed with sera from 24 potential male 
recipient sheep. Sixty-three of 77 (81.83%) were compatible and 14 (18.18%) were 
incompatible. 
 
Ovine Blood Transfusion 
After compatibility confirmation, 24 units of whole blood were transfused into 12 sheep 
recipients (2 units per sheep). During the 4 hours of monitoring post-transfusion, there was 
no evidence of any symptoms of adverse reaction (i.e. fever, tachycardia, hypotension, 
hypoxia or bleeding). 
 10 
Discussion 
Blood transfusion is a life-saving therapy used widely throughout clinical practice 
however it is not without risk. An increasing body of evidence has highlighted the non-
infectious risks of transfusion, particularly of stored blood products [16, 17]. While clinical 
trials investigating the possible association between age of blood and poor clinical outcomes 
will inform changes to clinical practice, clinically relevant animal models of transfusion are 
necessary to elucidate the underlying mechanisms. Central to the clinical validity of such 
models are the accurate assessment of the scope and the limitations of each specific animal 
model. Small animals (mice, rats, guinea pigs) have been used extensively as transfusion 
models [8, 18-21]. However, they present many anatomical, physiological and 
immunological differences compared to humans [22]. For example, rodents RBCs have 
significantly shorter lifespan than human and sheep RBCs (Table 2). For this reason, rodent 
blood undergoes a more rapid rate of deterioration under storage conditions compared to 
human erythrocytes and influences the duration of storage [7, 8, 19, 23]. In addition, the 
smaller size and lower blood volume dictates the use of centrifuge tubes rather than blood 
packs in collection, processing and storage of rodent blood (Table 2). This and restrictions on 
sampling volume, repeated measurements and follow-up also limit their clinical relevance.  
An ideal and clinically relevant animal model of blood transfusion would have 
anatomical and size similarities compared to humans, as well as comparative haematological 
and biochemistry values, analogous collection and processing protocols, not to mention the 
ease and expanse of care. Ovine models have been used extensively in medical research [24, 
25] as they having comparable size and anatomical similarities [26] to humans providing 
good surgical accessibility and possibilities for multiple sampling and follow-up. They also 
have comparative plasma and tissue pharmacokinetics [27], pulmonary circulation [28] and a 
placid nature, which is extremely useful during long in vivo studies [29]. Furthermore, as 
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their size and blood volume is similar to humans it is possible to collect a whole unit of blood 
in collection bags identical to those used for human blood donors. 
This study established normal haematology and biochemistry ranges for the Merino 
breed of sheep. These values were compared against those reported previously for humans. 
Ovine RBCs are smaller and more numerous than human RBCs. This corresponded with a 
lower range for ovine MCH compared to humans. In contrast, the range of ovine Hb, Hct and 
MCHC overlapped with the human normal range. These results together with the fact that the 
ovine RBC life span is very similar to that of human reveals some of the advantages ovine 
models have over other small animal models. 
To determine if ovine PRBC would adequately mimic human PRBC in the study of 
the effects of transfusing stored blood, we also monitored haematological and biochemical 
properties of ovine PRBC over 42-day storage period (Figure 2). Similar to human PRBC 
units, the rate of haemolysis evident in SAGM-containing ovPRBC units increased during 
storage. According to the Council of Europe Guideline [15], the haemolysis rate of human 
PRBC units at out-date (42 days) should not exceed 0.8%. In this study haemolysis on day 42 
was 0.81%  0.29, pointing towards a slightly accelerated rate of storage lesion development 
in ovPRBCs. In vivo survival of lamb PRBC after 40 day storage and transfusion [30] have 
been reported earlier. However, further studies are required to establish the viability and 
osmotic fragility of adult sheep PRBC during and after 42-day storage period. 
Potassium levels in stored human blood products increase over time, which may lead 
to severe levels of hyperkalemia (potassium > 5.5mmol/L), and this limits the shelf life of 
stored PRBC [23, 31]. Potassium in PRBC units is derived from RBC leakage, and levels in 
human PRBC range from 4 to 40mmol/L [32]. Ovine RBCs appear to be more stable as the 
potassium levels were considerably lower even on day 42.  
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The glucose levels decreased and lactic acid increased over time in ovPRBC but these 
changes were milder than what has been reported in human PRBC [23, 33]. In line with this 
the pH of ovine PRBC was stable over the entire storage period. Together these results 
suggest that metabolism of ovPRBC is slower. However, detailed investigation of ovPRBC 
biochemical changes, primarily adenosine triphosphate (ATP) and 2,3-diphosphoglycerate 
(2,3-DPG) level are required to confirm this. 
Pre-transfusion compatibility testing and blood typing in humans is vital and routine 
practise. However, in animal research it is primarily focused on high value animals, such as 
pets and horses. Our literature search found only rare reports of ovine pre-transfusion testing 
and the methodology listed contained little detail [34-36]. The diversity of blood groups in 
sheep and the lack of commercially available blood-typing reagents make complete typing 
and matching difficult. Therefore, we developed a modified saline agglutination method that 
can be easily added to the research protocol. Using this technique 18.2% of cross matches 
were found to be not compatible. This data challenges the presumption that single, 
unmatched whole blood transfusions are generally safe and well tolerated within an animal 
species. This unexpected high frequency of incompatibility emphasises importance pre-
transfusion compatibility testing especially in transfusion models.   
As discussed above an ovine model provides many advantages for the study of 
transfusion associated injuries, however its main limitation is that ovine RBCs are 
significantly smaller compared to that of humans [9, 37-40]. The smaller size of ovine RBC 
equates to a significantly higher surface area to volume ratio, and as a result ovine RBCs do 
not aggregate or deform as readily as RBCs of other species [41].  
In summary, this study presents a comprehensive validated ovine model of blood 
transfusion. Our results confirm the use of human blood bags for sheep blood collection with 
analogous blood bag processing, compatibility checking and transfusion procedures. In 
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addition, we established baseline haematological and biochemical parameters for healthy 
adult male Merino sheep and ovine PRBC units of various ages, and demonstrated the value 
of pre-transfusion compatibility testing. Together, these findings validate the application of 
the sheep model for blood transfusion studies and identify the advantages and limitations of 
an ovine transfusion model to assist future investigators design and select appropriate in vivo 
transfusion models.  
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Figure legends 
Figure 1 A range of typical ovine compatibility tests results. 0 = No agglutination, an 
even red cell suspension; 1 = Small agglutinates, with a lot of free red cells; 2 = Medium size 
agglutination, clear background; 4 = one solid agglutinate, no free red cells detected. 
 
Figure 2 Characterization of biochemical changes (haemolysis, potassium, glucose, 
lactate) in ovPRBCs (n=10) during 42 days storage. *P < 0.05 vs. day 1 for storage 
duration. The results are meanSD. 
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Figure2 
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Tables 
 
Table 1  
 
  
Human 
blood
# 
Ovine blood 
(n=12) 
Human PRBC units** 
(n=15) 
Ovine PRBC units 
(n=24) 
Parameters* Unit Range
 
Mean (±SD) Range Mean (±SD) Range Mean (±SD) Range 
RBCC  [10
12
/L] 4.60-6.00 11.41 (±1.14) 9.85-13.52 6.63 (±0.50) 5.84-7.52 13.74 (±1.87) 11.28-19.07 
Hb [g/L] 140-180 131.27 (±14.4) 115-156 198 (±10.74) 178-215 158.83(±15.37) 136-184 
Hct [%] 40-54 39.93 (±4.46) 35.0-48.4 60.49 (±0.03) 53.9-65.1 48.49 (±7.68) 39.0-71.3 
MCV  [fL] 80-100 34.99 (±1.56) 31.6-37.9 91.53 (±5.30) 79.7-102.0 35.25 (±1.63) 32.2-38.2 
MCH  [pg] 26-32 11.68 (±0.89) 10.8-14.1 29.97 (±1.63) 26.2-33.9 11.9 (±0.48) 11.2-12.7 
MCHC  [g/L] 320-360 327 (±8.25) 314-342 327.73 (±8.30) 310-337 329.08(±27.34) 249-350 
 
Table 1 Normal hematology values for healthy adult male sheep and fresh ovine PRBC. 
*
RBCC = red blood cell count; Hb = hemoglobin; 
Hct = haematocrit; MCV = mean cell volume; MCH = mean cell hemoglobin; MCHC = mean cell hemoglobin concentration. 
#
From Bernadette 
F. Rodak GAF & Elaine Keohane: Hematology: Clinical Principles and Applications, 4
th
 Edition edn: Elsevier. 
**
Unpublished data provided by 
Kristen Glenister, Research and Development, Australian Red Cross Blood Service, Melbourne. 
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Table 2 
 
 
Table 2 Benefits of an ovine model of transfusion 
 
 
 
Abbreviations 
TRALI = transfusion-related acute ling injury, TRIM = transfusion-related 
immunomodulation, PRBC = packed red blood cell, ATP = adenosine triphosphate,  
2,3-DPG = 2,3-diphosphoglycerate 
 Mice Rat Guinea pig Sheep Human 
Size 20-40 g 250-520 g 950-1060 g 30-60 kg 60-80 kg 
Blood volume 1.2-2.4 mL 16-32 mL 35-50 mL 2-4 L 4.4-5 L 
Red cell life 
span 
42 days [42] 65 days [42] 79 days [42] 
~120 days [9-
11] 
120 days [43] 
Blood 
collection 
Microtubes Microtubes 
Small blood 
bags (150mL) 
Blood packs 
(400-600mL) 
Blood packs 
(400-600mL) 
Storage lesion 7 days [7] 7 days [8] 28 days [19] N/A  42 days [15] 
